Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dreyer

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Journal of Natural Products|April 28, 2001
New insecticidal rocaglamide derivatives and related compounds from Aglaia oligophyllaM Dreyer, B W Nugroho, F I Bohnenstengel, et al.
The Journal of Experimental Medicine|March 27, 2013
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodiesAndrew T McGuire, Sam Hoot, Anita M Dreyer, et al.
STAR Protocols|June 14, 2023
Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assayLisa W Rodenburg, Isabelle S van der Windt, Henriette H M Dreyer, et al.
Glycobiology|June 18, 2019
Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidateNeil Ravenscroft, Martin Braun, Joerg Schneider, et al.
Elife|February 15, 2017
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibodyPaola Favuzza, Elena Guffart, Marco Tamborrini, et al.
Ebiomedicine|April 16, 2021
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionKawsar R Talaat, Cristina Alaimo, Patricia Martin, et al.
Protein Engineering|July 2, 1999
Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietinH Zhan, B Liu, S W Reid, et al.
Children (Basel, Switzerland)|June 28, 2023
Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract DisordersHenriette H M Dreyer, Eleonora Sofie van Tuyll van Serooskerken, Lisa W Rodenburg, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
Cell Reports. Medicine|March 24, 2026
Small molecule-directed differentiation of submerged-cultured human nasal airway epithelia for respiratory disease modelingHenriette H M Dreyer, Georgia-Nefeli Ithakisiou, Sacha Spelier, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of Natural Products|April 28, 2001
New insecticidal rocaglamide derivatives and related compounds from Aglaia oligophyllaM Dreyer, B W Nugroho, F I Bohnenstengel, et al.
The Journal of Experimental Medicine|March 27, 2013
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodiesAndrew T McGuire, Sam Hoot, Anita M Dreyer, et al.
STAR Protocols|June 14, 2023
Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assayLisa W Rodenburg, Isabelle S van der Windt, Henriette H M Dreyer, et al.
Glycobiology|June 18, 2019
Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidateNeil Ravenscroft, Martin Braun, Joerg Schneider, et al.
Elife|February 15, 2017
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibodyPaola Favuzza, Elena Guffart, Marco Tamborrini, et al.
Ebiomedicine|April 16, 2021
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionKawsar R Talaat, Cristina Alaimo, Patricia Martin, et al.
Protein Engineering|July 2, 1999
Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietinH Zhan, B Liu, S W Reid, et al.
Children (Basel, Switzerland)|June 28, 2023
Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract DisordersHenriette H M Dreyer, Eleonora Sofie van Tuyll van Serooskerken, Lisa W Rodenburg, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
Cell Reports. Medicine|March 24, 2026
Small molecule-directed differentiation of submerged-cultured human nasal airway epithelia for respiratory disease modelingHenriette H M Dreyer, Georgia-Nefeli Ithakisiou, Sacha Spelier, et al.
Pageof 12